| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |